Background

Respiratory disease places a huge burden on society in terms of disability and premature mortality, and also in direct health service costs, drugs prescribed and the indirect costs related to lost production. This chapter estimates these costs across the current 28 member countries of the European Union using published cost estimates and WHO and European data. Because of a lack of information related to other respiratory diseases, costs are estimated for only the more common conditions: chronic obstructive pulmonary disease (COPD), asthma, lung cancer, tuberculosis (TB), pneumonia/acute lower respiratory infections (ALRI), obstructive sleep apnoea syndrome (OSAS) and cystic fibrosis. The analysis is limited to countries of the EU because of the paucity of representative data relevant to most non EU countries.

See the entire Economic Burden of Lung Disease Chapter